Dr. Terrence Cescon
Expert in Cancer
Expert in Adenocarcinoma
56 reported clinical trials
107 drugs studied
1 year of experience
About Terrence Cescon
- Obtained MD from Drexel University College of Medicine in 2015.
- Completed Residency in Internal Medicine at Reading Hospital, serving as Chief Resident (2018-2019).
- Finished Fellowship in Hematology/Oncology at Fox Chase Cancer Center in 2022.
- Specializes in Hematology/Oncology with comprehensive training and experience based in Pennsylvania, United States.
Area of expertise
Terrence Cescon has run 18 trials for Cancer. Some of their research focus areas include:
Terrence Cescon has run 11 trials for Adenocarcinoma. Some of their research focus areas include:
Reading Hospital - McGlinn Cancer Institute
Clinical Trials Terrence Cescon is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
More about Terrence CesconClinical Trial Related1 year of experience running clinical trials · Led 56 trials as a Principal Investigator · 28 Active Clinical Trials
Treatments Terrence Cescon has experience with
Breakdown of trials Terrence Cescon has run
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Terrence Cescon specialize in?
Terrence Cescon focuses on Cancer and Adenocarcinoma. In particular, much of their work with Cancer has involved Stage III patients, or patients who are Stage IV.
Is Terrence Cescon currently recruiting for clinical trials?
Yes, Terrence Cescon is currently recruiting for 23 clinical trials in West Reading Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Terrence Cescon has studied deeply?
Yes, Terrence Cescon has studied treatments such as Paclitaxel, Nivolumab, Fluorouracil.
What is the best way to schedule an appointment with Terrence Cescon?
Apply for one of the trials that Terrence Cescon is conducting.
What is the office address of Terrence Cescon?
The office of Terrence Cescon is located at: Reading Hospital, West Reading, Pennsylvania 19611 United States. This is the address for their practice at the Reading Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.